Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

[Preparation and Application of Monoclonal Antibody Against Human Von Willebrand Factor Propeptide].

Preparation and Characterization of Monoclonal AntibodyAgainst Human Von Willebrand Factor

Preparation of A Monoclonal Antibody Against Human Von Willebrand Factor A1 Domain

[Expression of the Metalloproteinase Domain of Von Willebrand Factor-Cleaving Protease and Preparation of Its McAb].

Development,identification and Function Assay of Monoclonal Antibody Against Platelet Membrane Glycoprotein Ib

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.

[Preparation and preliminary application of rabbit polyclonal antibodies against intracellular peptides of human platelet glycoprotein GPIbalpha].

Epitope Mapping of Human VWF A3 Recognized by Monoclonal Antibody SZ-123 and SZ-125 Using MALDI Mass Spectrometry

Development Of An Elisa Method For Testing Vwf Ristocetin Cofactor Activity With Improved Sensitivity And Reliability In The Diagnosis Of Von Willebrand Disease

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

[Preparation and Identification of the Polyclonal Antibody Against Human VSTM1].

Establishment and Clinical Application of Flow Cytometric Immunobead Array in Detecting Plasma Von Willebrand Factor Antigen

[Preparation of Monoclonal Antibodies Against Human Apo B₁₀₀ and Establishment of a Sandwich ELISA System].

[Identification of Monoclonal Antibodies Against Von Willebrand Factor Cleaving Protease (ADAMTS13) and Their Function].

Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction.

Characterization and Functional Studies of Vwf A3 Domain Monoclonal Antibodies That Inhibit Binding of Vwf to Collagen

Preparation,identification and preliminary application of monoclonal antibodies against recombinant human basic fibroblast growth factor

[Eukaryotic Expression of Von Willebrand Factor A1A2A3 Triplet and Its Biological Activity].

[Preparation of Monoclonal Antibody Based on Single Intrasplenic Immunization of Plasmid DNA].